Bristol-Myers Squibb Company
Compounds useful as immunomodulators
Last updated:
Abstract:
The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.
Status:
Grant
Type:
Utility
Filling date:
11 Oct 2016
Issue date:
18 Aug 2020